Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients
Objective: To compare the clinical characteristics and outcomes of HIV-1-HTLV-1 coinfected patients, in Bahia, Brazil. Methods: Retrospective, comparative study. Results: Among a total of 123 consecutive HIV infected patients, 20 men (20.6%) and 6 women (23.1%) had detectable antibodies against HTLV...
Main Authors: | C. Brites, F. Goyanna, L.G. França, C. Pedroso, E.M. Netto, S. Adriano, J. Sampaio, W. Harrington, Jr |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2011-01-01
|
Series: | Brazilian Journal of Infectious Diseases |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1413867011701325 |
Similar Items
-
Coinfection by HTLV-I/II is associated with an increased risk of strongyloidiasis and delay in starting antiretroviral therapy for AIDS patients
by: C Brites, et al. -
COVID-19 and strongyloidiasis: what to expect from this coinfection?
by: Carolina Victoria Marcitelli Pereira, et al.
Published: (2021-11-01) -
The impact of HTLV-1 infection on clinical and immunological outcomes in patients coinfected with HIV and hepatitis C virus
by: Netto Eduardo, et al.
Published: (2011-06-01) -
Comparison of functioning and health-related quality of life among patients with HTLV-1, HIV, and HIV-HTLV-1-coinfection
by: Cleyde Sheyla Chachaqui Marconi, et al.
Published: (2021-03-01) -
Stability of an HTLV-HIV coinfection model with multiple delays and CTL-mediated immunity
by: N. H. AlShamrani
Published: (2021-05-01)